Moderation and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...

Customs and Border Protection agents in Cincinnati have seized shipments of unapproved weight loss drugs arriving from ...

Semaglutide remains on the agency’s drug shortage list, but all FDA-approved forms of the drug are no longer labeled ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in overweight patients with cardiovascular disease.

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

A retrospective cohort study using data from patients in 21 countries showed use of semaglutide use was not linked to an ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and ...